Concentration-Controlled Trials
- 1 February 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 28 (2) , 93-99
- https://doi.org/10.2165/00003088-199528020-00001
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Application of Pharmacokinetically Guided Dose Escalation With Respect to Cell Cycle Phase SpecificityJNCI Journal of the National Cancer Institute, 1994
- Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I TrialJNCI Journal of the National Cancer Institute, 1993
- Concentration-controlled versus concentration-defined clinical trialsClinical Pharmacology & Therapeutics, 1993
- A Comparison of Valproate with Carbamazepine for the Treatment of Complex Partial Seizures and Secondarily Generalized Tonic–Clonic Seizures in AdultsNew England Journal of Medicine, 1992
- The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: Critical evaluation and recommendations for future studiesAnnals of Oncology, 1992
- Use of adaptive control with feedback to individualize suramin dosing.1992
- Compliance During Treatment of EpilepsyEpilepsia, 1988
- THERAPEUTIC RESPONSE IN PHASE-I TRIALS OF ANTINEOPLASTIC AGENTS1986
- PHASE-I AND PHARMACOKINETIC STUDY OF LM985 (FLAVONE ACETIC-ACID ESTER)1986
- Predictability of Phenytoin Serum Levels by Nomograms and CliniciansEuropean Neurology, 1980